Unleash the power of mNGS to identify infectious agents in complex human samples
02 Sep 2022

A major challenge to enhance the use of mNGS for the identification of infectious agents is linked to the vast excess of human DNA, which negatively impacts sequencing results, sensitivity and the overall workflow. In this webinar, we will discuss how human DNA depletion by MolYsis™ can help overcome such limitations, improve sequencing depth and quality, and reduce the time and costs of analysis.

Key learning objectives:

  • Learn more about the challenges and opportunities of mNGS in clinical infection diagnosis
  • Learn how to increase sequencing depth and quality of microbial reads by depleting human DNA from body fluids, tissues and swabs
  • Learn how MolYsis™ impacts the number of sequencing reads, sequencing time and overall data cost
  • Learn how to facilitate the mNGS workflow for the identification of bacteria and fungi

Who should attend?

  • Lab directors, lab managers and quality managers
  • Medical laboratory scientists and technicians
  • Molecular microbiologists
  • Clinical lab scientists
  • Clinicians, infectious disease specialists and pathologists
  • Researchers, microbiologists and biotechnologists

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

Molzym GmbH & Co. KG